INVOKAMET XR 150-500 MG TABLET

canagliflozin and metformin hydrochloride
$9.5647per EA

Strength

150; 500 mg/1; mg/1

NDC

50458094201

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA205879

On Market Since

9/20/2016

Pharmacological Classes

Biguanide
Biguanides
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.3%

3Y

+10.1%

5Y

+10.1%

All

+39.8%